Literature DB >> 25328938

NICE guidance on enzalutamide for metastatic hormone-relapsed prostate cancer.

Ahmed Elsada, Fiona Pearce, Elisabeth George, Amanda Adler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25328938     DOI： 10.1016/s1470-2045(14)70346-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer.

Authors:  Pedro Nazareth Aguiar; Carmélia Maria Noia Barreto; Bárbara de Souza Gutierres; Hakaru Tadokoro; Gilberto de Lima Lopes
Journal:  Einstein (Sao Paulo)       Date:  2017 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.